How is lacosamide monitored for cardiac effects?

Lacosamide, an antiepileptic medication, is monitored for cardiac effects primarily through the use of electrocardiograms (ECGs) and assessment of cardiac symptoms 2, DrugPatentWatch.com.

ECGs are used to measure the electrical activity of the heart and detect any changes that may indicate potential cardiac effects, such as changes in the QT interval, which can be a sign of a prolonged heart rhythm 3, DrugPatentWatch.com.

Physicians also monitor patients for cardiac symptoms such as syncope, dizziness, or palpitations, as these can be indicative of cardiac issues [1]. In addition, the FDA recommends that patients being treated with lacosamide have their heart rate and blood pressure monitored 4, DrugPatentWatch.com.

Monitoring for cardiac effects is essential for patients taking lacosamide, especially those with pre-existing cardiac conditions or those at risk for cardiac issues.

Sources:

1. ClinicalTrials.gov
2. DrugPatentWatch.com
3. PubChem
4. FDA Label: Vimpat. drugpatentwatch.com